KLC2 and Hepatic fibrosis: We did not observe an association between KLC2 expression and other clinical or pathological parameters (e.g., age, gender, performance status, progression-free or disease-specific survival, etiology, liver fibrosis stage, tumor grading, and vascular invasion; each p > 0.05).